Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 796 | 209 | 312 | N/A | 1 |
| TOTAL | $801 | $214 | $317 | $N/A | $1 |
| Non-Current Assets | |||||
| Intangibles | 219 | 219 | 220 | 1 | 2 |
| TOTAL | $219 | $219 | $220 | $1 | $2 |
| Total Assets | $1,020 | $434 | $536 | $1 | $3 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26 | 16 | 17 | 0 | 4 |
| Other current liabilities | 547 | N/A | 18 | 23 | 9 |
| TOTAL | $572 | $16 | $35 | $23 | $14 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $572 | $16 | $35 | $23 | $14 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 730 | 719 | 719 | 719 | 51 |
| Common Shares | 3 | 3 | 3 | N/A | 5 |
| Retained earnings | -941 | -227 | -142 | N/A | -72 |
| TOTAL | $448 | $418 | $501 | $N/A | $-11 |
| Total Liabilities And Equity | $1,020 | $434 | $536 | $23 | $3 |